Literature DB >> 9890081

Is functional dyspepsia just a subset of the irritable bowel syndrome?

W E Whitehead1, N A Gibbs, Z Li, D A Drossman.   

Abstract

To determine whether functional dyspepsia and irritable bowel syndrome are different entities, epidemiological data, factor analysis studies, physiological data and associated psychological symptoms were reviewed. Between 30% and 60% of patients with either diagnosis also meet the criteria for the other diagnosis, a level greater than expected to occur by chance but not sufficient to infer an identity. Most factor analysis studies identify independent clusters of symptoms corresponding to functional dyspepsia and irritable bowel syndrome. Visceral hypersensitivity is seen throughout the gastrointestinal tract in both disorders, but the motility patterns seen in association with functional dyspepsia (principally antral hypomotility and delayed gastric emptying) differ from the motility patterns seen in irritable bowel syndrome. Psychological symptoms are similar in these two disorders but are not believed to be aetiological for either of them. Thus, based on a factor analysis of gastrointestinal symptoms and differences in intestinal motility, functional dyspepsia and irritable bowel syndrome appear to be different entities.

Entities:  

Mesh:

Year:  1998        PMID: 9890081     DOI: 10.1016/s0950-3528(98)90017-3

Source DB:  PubMed          Journal:  Baillieres Clin Gastroenterol        ISSN: 0950-3528


  12 in total

Review 1.  The functional gastrointestinal disorders and the Rome II process.

Authors:  D A Drossman
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Irritable bowel syndrome: patterns of ambulatory health care and resource use in the United States, 1993-1997.

Authors:  Jennifer Hollowell; Annika Lundgren; Saga Johansson
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

3.  Racial differences in epidemiology of irritable bowel syndrome alone, un-investigated dyspepsia alone, and "overlap syndrome" among african americans compared to Caucasians: a population-based study.

Authors:  Anil Minocha; William Chad; Wigington Do; William D Johnson
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

4.  Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool.

Authors:  Michael D Crowell; Sarah B Umar; Brian E Lacy; Michael P Jones; John K DiBaise; Nicholas J Talley
Journal:  Dig Dis Sci       Date:  2015-04-05       Impact factor: 3.199

5.  Rectal distension modulates canine gastric tone and accommodation.

Authors:  Yong Lei; Hongbing Zhu; Jinhong Xing; J D Z Chen
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

Review 6.  Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review.

Authors:  William E Whitehead; Douglas A Drossman
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

7.  What does pain or discomfort in irritable bowel syndrome mean?

Authors:  Masanori Handa; Hideyuki Nukina; Katsumi Ando; Chiharu Kubo
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

8.  Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.

Authors:  Moritz von Wulffen; Nicholas J Talley; Johann Hammer; Jessica McMaster; Graeme Rich; Ayesha Shah; Natasha Koloski; Bradley J Kendall; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2018-10-27       Impact factor: 3.199

9.  Psychopathological features of irritable bowel syndrome patients with and without functional dyspepsia: a cross sectional study.

Authors:  Daria Piacentino; Rosanna Cantarini; Marianna Alfonsi; Danilo Badiali; Nadia Pallotta; Massimo Biondi; Enrico S Corazziari
Journal:  BMC Gastroenterol       Date:  2011-08-26       Impact factor: 3.067

10.  Functional gastrointestinal disorder is associated with increased non-gastrointestinal healthcare consumption in the general population.

Authors:  T Alander; K Svärdsudd; L Agréus
Journal:  Int J Clin Pract       Date:  2007-11-21       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.